STADA Arzneimittel AG Eyes Merck KGaA's Generics Unit Say Sources
FRANKFURT, March 8 (Reuters) - German generics drugmaker Stada Arzneimittel (STAGn.DE: Quote, Profile , Research) is interested in participating in the first round of bidding for Merck KGaA's (MRCG.DE: Quote, Profile , Research) generics business, industry sources said on Thursday. Stada was not immediately available for comment.